Skip to main content

Advertisement

Table 4 Number and percentage of CIN2+ cases based on the biopsies according to cytology result and previous radiotherapy status read under FPGS orientation

From: Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study

Cytology result No previous radiotherapy Previous radiotherapy PR 95% CI (PR)
N (%) N (%)
ASCUS + ASCH + AGC 41 (32.5) 10 (50.0) 1.54 0.93 – 2.55
LSIL 20 (15.9) 2 (10.0) 0.63 0.16 – 2.49
HSIL or worse 65 (51.6) 8 (40.0) 0.78 0.44 – 1.36